Literature DB >> 9564572

Gastrointestinal complications of chronic granulomatous disease: case report and literature review.

L L Barton1, S L Moussa, R G Villar, R L Hulett.   

Abstract

Chronic granulomatous disease (CGD), an inherited disorder of phagocytic leukocyte function, is characterized by recurrent infections with catalase-positive organisms. Gastrointestinal (GI) tract involvement, present in the majority of affected individuals, may be present initially and recurrently, mimics other entities such as inflammatory bowel disease, and causes substantive morbidity and mortality. Disorders of motility, ulceration, obstruction, and infection (e.g., abscesses) occur from the mouth to the anus and stereotypically manifest with vomiting, diarrhea, abdominal pain, weight loss, and fever. Careful physical examination, in concert with appropriate diagnostic studies, is necessary to delineate intraabdominal pathologic processes. Abdominal radiographs, ultrasonography, computerized tomography, and endoscopy are useful ancillary diagnostic procedures. Drainage of accessible abscesses, antimicrobial therapy based on organisms cultured from blood and tissue, and interferon gamma may lead to suppression or eradication of infections and resolution of symptoms. Corticosteroids are useful for gastric outlet obstruction and sulfasalazine and cyclosporine for large bowel disease. Gallbladder dysfunction may be ameliorated, as in our patient, with administration of cholestyramine.

Entities:  

Mesh:

Year:  1998        PMID: 9564572     DOI: 10.1177/000992289803700403

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  22 in total

1.  Gastrointestinal Manifestations of Non-AIDS Immunodeficiency.

Authors:  Robert P. McCabe
Journal:  Curr Treat Options Gastroenterol       Date:  2002-02

Review 2.  Chronic granulomatous disease.

Authors:  D Goldblatt; A J Thrasher
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

3.  Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients.

Authors:  Meghna Alimchandani; Jin-Ping Lai; Phyu Phyu Aung; Sajneet Khangura; Natasha Kamal; John I Gallin; Steven M Holland; Harry L Malech; Theo Heller; Markku Miettinen; Martha M Quezado
Journal:  Am J Surg Pathol       Date:  2013-09       Impact factor: 6.394

Review 4.  Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes.

Authors:  Shradha Agarwal; Lloyd Mayer
Journal:  J Allergy Clin Immunol       Date:  2009-08-08       Impact factor: 10.793

5.  Colitis in chronic granulomatous disease.

Authors:  M G Schäppi; V V Smith; D Goldblatt; K J Lindley; P J Milla
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

6.  Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis.

Authors:  Gulbu Uzel; Jordan S Orange; Nina Poliak; Beatriz E Marciano; Theo Heller; Steven M Holland
Journal:  Clin Infect Dis       Date:  2010-11-08       Impact factor: 9.079

7.  Hepatic abscess in patients with chronic granulomatous disease.

Authors:  Matthew Lublin; David L Bartlett; David N Danforth; Howard Kauffman; John I Gallin; Harry L Malech; Thomas Shawker; Peter Choyke; David E Kleiner; Douglas J Schwartzentruber; Richard Chang; Ellen S DeCarlo; Steven M Holland
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

Review 8.  Spectrum of imaging findings of chronic granulomatous disease: a single center experience.

Authors:  Minah Lee; Mu Sook Lee; Jeong Sub Lee; Su Yeon Ko; Sun Young Jeong
Journal:  Diagn Interv Radiol       Date:  2017 Nov-Dec       Impact factor: 2.630

9.  Gastrointestinal fistulae in chronic granulomatous disease.

Authors:  Lakshmi Gopal; Joanne Forbes; Gulbu Uzel; Steven M Holland; Theo Heller
Journal:  Am J Gastroenterol       Date:  2009-05-12       Impact factor: 10.864

Review 10.  Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency.

Authors:  Shradha Agarwal; Lloyd Mayer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-13       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.